APOC3 and diabetes mellitus: As in ECs, diabetes enhanced inflammatory signatures, including antigen processing, integrins, and senescence signaling, which were prevented by hepatic APOC3 silencing, with response to lipopolysaccharide as a major predicted upstream regulator (Extended Data Fig. 9c).